quinazolines has been researched along with Erythema in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (30.77) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (38.46) | 29.6817 |
| 2010's | 4 (30.77) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, YQ; Sun, H; Xue, D | 1 |
| Ballester-Sánchez, R; de Unamuno-Bustos, B; Sabater Marco, V; Vilata-Corell, JJ | 1 |
| Fujiwara, K; Hosokawa, A; Ichiba, Y; Kajiume, S; Kiba, T; Kimoto, S; Nakano, K; Nakashima, T; Ogawa, Y; Okada, Y; Taniguchi, H | 1 |
| Ladizinski, B; Sankey, C | 1 |
| Descourt, R; Misery, L; Roguedas, AM; Rouxel, AM | 1 |
| Dummer, R; Follath, F; Jacky, E; Trojan, A | 1 |
| Elsner, P; Hamburger, M; Heinemann, C; Oberthür, C; Schliemann-Willers, S | 1 |
| Brown, DA; Canning, MT; Galvin, JW; Nay, SL; Peña, AV; Yarosh, DB | 1 |
| Chu, CY; Hsiao, CH; Sheen, YS | 1 |
| Fujimura, H; Hasegawa, J; Kyuki, K; Niwa, M; Tsurumi, K; Yasuda, K | 1 |
| Johansson, EA | 1 |
| Fujimura, H; Hiramatsu, Y; Nozaki, M; Tamura, Y; Tsurumi, K | 1 |
| Awata, H; Inaba, S; Saito, C; Yamamoto, H; Yamamoto, M | 1 |
1 review(s) available for quinazolines and Erythema
| Article | Year |
|---|---|
A severe dermatologic adverse effect related with gefitinib: case report and review of the literature.
Topics: Antineoplastic Agents; Bone Neoplasms; Carcinoma, Non-Small-Cell Lung; Edema; Erythema; Gefitinib; Humans; Lung Neoplasms; Male; Middle Aged; Quinazolines | 2013 |
4 trial(s) available for quinazolines and Erythema
| Article | Year |
|---|---|
[Prospective study of biotin treatment in patients with erythema due to gefitinib or erlotinib].
Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Biotin; Carcinoma, Non-Small-Cell Lung; Erlotinib Hydrochloride; Erythema; Female; Gefitinib; Humans; Lung Neoplasms; Male; Prospective Studies; Protein Kinase Inhibitors; Quinazolines | 2014 |
Prevention of experimentally induced irritant contact dermatitis by extracts of Isatis tinctoria compared to pure tryptanthrin and its impact on UVB-induced erythema.
Topics: Adolescent; Adult; Anti-Inflammatory Agents; Dermatitis, Allergic Contact; Drugs, Chinese Herbal; Erythema; Female; Humans; Isatis; Male; Phytotherapy; Plant Extracts; Plant Leaves; Quinazolines; Single-Blind Method; Sodium Dodecyl Sulfate; Treatment Outcome; Ultraviolet Rays | 2004 |
Anti-inflammatory activity in skin by biomimetic of Evodia rutaecarpa extract from traditional Chinese medicine.
Topics: Administration, Cutaneous; Adult; Alkaloids; Anti-Inflammatory Agents; Biomimetics; Cell Line; Dinoprostone; Dose-Response Relationship, Drug; Drugs, Chinese Herbal; Erythema; Evodia; Furans; Heterocyclic Compounds, 4 or More Rings; Humans; Indole Alkaloids; Keratinocytes; Middle Aged; Nicotinic Acids; Nitric Oxide; Plant Extracts; Quinazolines; Skin; Time Factors; Ultraviolet Rays | 2006 |
Proquazone: a treatment for lymphocytic infiltration of the skin. Comparative study with 2 other nonsteroid anti-inflammatory drugs.
Topics: Adult; Aged; Clinical Trials as Topic; Erythema; Female; Humans; Ibuprofen; Indomethacin; Lymphocytes; Male; Middle Aged; Quinazolines | 1987 |
8 other study(ies) available for quinazolines and Erythema
| Article | Year |
|---|---|
Dermatomyositis-like eruption associated with hydroxyurea therapy: a premalignant condition?
Topics: Aged; Dermatomyositis; Diagnosis, Differential; Drug Eruptions; Drug Substitution; Erythema; Female; Humans; Hydroxyurea; Leg Ulcer; Lichenoid Eruptions; Precancerous Conditions; Primary Myelofibrosis; Quinazolines | 2014 |
A topical matter: toxic epidermal necrolysis.
Topics: Acetaminophen; Analgesics, Opioid; Anti-Inflammatory Agents; Anticonvulsants; Antiemetics; Antineoplastic Agents; Dacarbazine; Dexamethasone; Drug Combinations; Erythema; gamma-Globulins; Glioblastoma; Humans; Immunologic Factors; Levetiracetam; Male; Methylprednisolone; Middle Aged; Omeprazole; Oxycodone; Piperidines; Piracetam; Proton Pump Inhibitors; Quinazolines; Stevens-Johnson Syndrome; Temozolomide; Wound Healing | 2014 |
[Hand-foot syndrome: A new side effect of erlotinib].
Topics: Aged; Diagnosis, Differential; ErbB Receptors; Erlotinib Hydrochloride; Erythema; Foot Dermatoses; Foot Diseases; Hand Dermatoses; Humans; Lung Neoplasms; Male; Protein Kinase Inhibitors; Quinazolines; Syndrome | 2008 |
Necrolytic migratory erythema (glucagenoma)-like skin lesions induced by EGF-receptor inhibition.
Topics: Carcinoma, Non-Small-Cell Lung; Epidermal Growth Factor; Erythema; Female; Gefitinib; Humans; Lung Neoplasms; Middle Aged; Protein-Tyrosine Kinases; Quinazolines | 2003 |
Severe purpuric xerotic dermatitis associated with gefitinib therapy.
Topics: Adult; Aged; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Drug Eruptions; Erythema; Female; Gefitinib; Humans; Leg; Lung Neoplasms; Male; Purpura; Quinazolines | 2008 |
Effect of the new antiallergic drug 11-oxo-11H-pyrido[2,1-b]quinazoline-2-carboxylic acid on inflammatory reactions and platelet aggregation.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Capillary Permeability; Diarrhea; Edema; Erythema; Guinea Pigs; Hypersensitivity; Male; Mice; Platelet Aggregation; Quinazolines; Rats; Rats, Inbred Strains; Wound Healing | 1986 |
[Pharmacological studies on quinazoline-2, 4-dione derivaties, H-27 and H-88: (1) anti-inflammatory, analgesic and antipyretic activities].
Topics: Adrenalectomy; Analgesics; Animals; Anti-Inflammatory Agents; Arthritis, Rheumatoid; Body Temperature; Body Weight; Capillary Permeability; Cordotomy; Drug Evaluation, Preclinical; Edema; Erythema; Female; Granulation Tissue; Hemolysis; Lethal Dose 50; Male; Mice; Quinazolines; Rabbits; Rats | 1974 |
Novel quinazoline derivatives. II. A new anti-inflammatory agent, SL-512.
Topics: Analgesics; Animals; Anti-Inflammatory Agents; Arthritis; Capillary Permeability; Cyclopropanes; Edema; Erythema; Granuloma; Guinea Pigs; Intestinal Perforation; Lethal Dose 50; Male; Mefenamic Acid; Mice; Peritonitis; Phenylbutazone; Quinazolines; Rats | 1973 |